Dorina Adelina Minciuna

Dr. Dorina Adelina Minciuna

UMF Grigore T Popa Iasi, Iaşi, Romania
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PVPetronela Vicoveanu
Petronela Vicoveanu
I(Ingrid Andrada Tanasa (Vasilache)
Ingrid Andrada Tanasa (Vasilache)
DNDragos Nemescu
Dragos Nemescu
ACAlexandru Carauleanu
Alexandru Carauleanu
SSSadiye Ioana Scripcariu
Sadiye Ioana Scripcariu
Socolov DemetraSocolov Demetra
Socolov Demetra
Background: Pregnancy in women with systemic lupus erythematosus (SLE) is accompanied by adverse pregnancy outcomes (APOs). We aimed to investigate the association between clinical, sonographic, and laboratory parameters and APOs (preeclampsia, intrauterine growth restriction, premature birth, and maternal mortality). Methods: This observational retrospective study included all pregnancies in women with SLE who attended two tertiary maternity hospitals from Romania between January 2013 and December 2020. Clinical, sonographic, and laboratory variables were examined. Bivariate associations of APO status and each predictor variable were evaluated, and significant predictors were further included in a classification model based on discriminant analysis. Results: Predictors of APOs included BMI > 25 kg/m2, personal history of lupus nephritis or chronic hypertension, proteinuria, low C3, SLE Disease Activity Index 2000 (SLEDAI-2k score ≥ 4 and physician’s global-assessment (PGA) score ≥ 1 throughout pregnancy, increased mean uterine arteries pulsatility index in the first and second trimesters, cerebroplacental ratio < 1 in the second and third trimesters, and small fetal abdominal circumference in the third trimester. Glucocorticoids, methyldopa, and aspirin use appeared to be protective against APOs. Conclusions: This study provides a comprehensive analysis of the most important predictors for APOs in pregnant patients with SLE, which could constitute a basis for further research.

1 September 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
RHRaluca Maria Haba
Raluca Maria Haba
APAnda Ioana Pristavu
Anda Ioana Pristavu
MCMaria Luiza Cobzeanu
Maria Luiza Cobzeanu
ACAlexandru Carauleanu
Alexandru Carauleanu
SSSadiye Ioana Scripcariu
Sadiye Ioana Scripcariu
Socolov DemetraSocolov Demetra
Socolov Demetra
Background: Placenta accreta spectrum (PAS) disorders are associated with high mortality and morbidity due to postpartum hemorrhage, hysterectomy, and organ injury, and a multidisciplinary team is required for an individualized case management. In this study, we assessed the diagnostic and prognostic accuracy of the most important ultrasonographic (US) and magnetic resonance imagining (MRI) markers for PAS disorders. Material and Methods: The study included 39 adult pregnant patients with at least one previous cesarean delivery and both US and MRI investigations for placenta previa evaluated at the tertiary maternity hospital ‘Cuza Voda’, Iasi, between 2019 and 2021. The following US signs were evaluated: intra-placental lacunae, loss of the retroplacental hypoechoic zone, myometrial thinning < 1 mm, bladder wall interruption, placental bulging, bridging vessels, and the hypervascularity of the uterovesical or retroplacental space. The MRI signs that were evaluated were intra-placental dark T2 bands, placental bulging, loss of the retroplacental hypointense line on T2 images, myometrial thinning, bladder wall interruption, focal exophytic placental mass, and abnormal vascularization of the placental bed. Results: The US and MRI signs analyzed in our study presented adequate sensitivities and specificities for PAS, but no sign proved to be a useful predictor by itself. The presence of three or more US markers for accretion was associated with a sensitivity of 84.6.6% and a specificity of 92.3% (p < 0.001). The presence of three or more MRI signs supplemented these results and were associated with a sensitivity of 92.3% and a specificity of 61.5% for predicting PAS (p < 0.001). Moreover, US and MRI findings were correlated with FIGO grading and severity of PAS. Conclusions: Even though no US or MRI finding alone can predict PAS with high sensitivity and specificity, our study proves that the presence of three or more imagistic signs could significantly increase the diagnostic accuracy of this condition. Furthermore, US and MRI could be useful tools for evaluating prognostic and perinatal planning.

15 November 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
TBTudor Butureanu
Tudor Butureanu
Socolov DemetraSocolov Demetra
Socolov Demetra
DMDaniela-Roxana Matasariu
Daniela-Roxana Matasariu
AUAlexandra Ursache
Alexandra Ursache
AAAna-Maria Apetrei
Ana-Maria Apetrei
LLLudmila Lozneanu
Ludmila Lozneanu
A common problem in gynecological practice is the differential diagnosis of the ovarian masses. The clinician must apply the IOTA (International Ovarian Tumor Analysis) ADNEX (Assessment of Different Neoplasia in the Adnexa) model criteria to evaluate the risk of benign, borderline or malignant tumors. The aim of this study was to verify if the IOTA ADNEX model is a practical tool to be used before surgery and if there is a significant difference between IOTA ADNEX criteria and histological findings. A prospective single center study was performed between January 2017 and December 2019 in Obstetrics and Gynecology Hospital “Cuza-Voda”, Iasi, Romania. The study included 230 patients between 17 and 74 years old diagnosed with persistent adnexal masses. We applied the IOTA ADNEX model protocol predicting the risk of benign, borderline or malignant masses. The golden standard remains the histological diagnosis of the surgically removed mass. The patients that had been diagnosed using ultrasonography with persistent adnexal masses between 30 and 291 mm were operated on in our clinic. In our study. the majority of patients had benign ovarian tumor mass, these being 223 (96.96%) patients, from whom, according to IOTA ADNEX protocol, the correspondence was: 91.8–99.7% at risk of benign tumors, 0.3–4.5% at risk of borderline tumors and 0.3–8.2% at risk of malignant masses. Unexpected findings were obtained from the malignant group that included five patients (2.17%) with the following correspondence: 96.1–99% at risk of benign tumors, 0.6–2.4% at risk of borderline tumors and 1–3.9% at risk of malignant masses. After applying the IOTA ADNEX model criteria, the patients with a suspicion of malignant disease were correctly guided towards surgical treatment in an oncological center. In our hospital, surgical treatment was only proposed to those patients with high suspicion of benign masses.

19 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CMCosmin Minciuna
Cosmin Minciuna
DMDorina Adelina Minciuna
Dorina Adelina Minciuna
ADAngela Dascalescu
Angela Dascalescu
ATAmalia Titieanu
Amalia Titieanu
VCVlad Andrei Cianga
Vlad Andrei Cianga
LMLucian Miron
Lucian Miron
Background/Objectives: Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous malignancy with variable outcomes. Accurate risk prediction at diagnosis remains essential to guide treatment and follow-up strategies. In this retrospective study we aimed to assess the performance of multiple modeling approaches to predict death by 26 months of follow-up in patients with DLBCL using data available in the diagnostic stage. Methods: In this study we included 412 patients with DLBCL who were evaluated, treated, and followed-up at the Regional Institute of Oncology in Iasi, Romania, between 2015 and 2023. Clinical and paraclinical data determined at baseline examination was used to train and test six machine learning models (logistic regression, random forest—RF, support vector machine with a radial-basis kernel—SVM-RBF, multilayer perceptron neural network—MLP, random survival forest—RSF, and extreme gradient boosting—XGBoost) and to compare their performance to the Cox proportional hazards model. Results: Among the models, RF achieved the highest discrimination (AUC = 0.9060), with balanced performance (accuracy = 0.833; F1 = 0.902), followed by XGBoost (AUC = 0.8335) and MLP (AUC = 0.7861; accuracy = 0.849). RF and logistic regression demonstrated the best calibration (Brier = 0.360 and 0.377). The Cox model achieved moderate discrimination (time-dependent AUC = 0.5561; C-index = 0.55). Conclusions: Our findings align with contemporary reports showing that machine learning frameworks can outperform classical prediction approaches.

31 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DMDorina Adelina Minciuna
Dorina Adelina Minciuna
CHCristian Haba
Cristian Haba
RHRaluca Maria Haba
Raluca Maria Haba
CMCosmin Minciuna
Cosmin Minciuna
ACAlexandru Carauleanu
Alexandru Carauleanu
Socolov DemetraSocolov Demetra
Socolov Demetra
Fetal growth restriction (FGR) has traditionally been attributed to placental insufficiency. However, accumulating evidence suggests that maternal cardiovascular maladaptation contributes to disease expression, clinical heterogeneity, and long-term maternal cardiovascular risk. To review maternal echocardiographic findings in pregnancies complicated by FGR, with or without preeclampsia and to explore the role of cardiovascular phenotyping in risk stratification and clinical management. Narrative review of the current literature, including observational studies, systematic reviews, meta-analyses, and expert consensus statements on maternal hemodynamics and echocardiographic assessment in FGR. FGR is associated with a maladaptive cardiovascular profile characterized by reduced cardiac output, increased systemic vascular resistance and adverse cardiac remodeling. Echocardiography frequently identifies subclinical myocardial dysfunction, including impaired diastolic function and reduced global longitudinal strain despite preserved ejection fraction. Distinct maternal cardiovascular phenotypes emerge across the FGR spectrum, ranging from high-risk hypodynamic, resistance-dominant phenotypes to intermediate and low-risk phenotypes with preserved hemodynamic adaptation. Integration of maternal cardiovascular assessment with fetal Doppler findings may improve risk stratification and support phenotype-guided surveillance and therapeutic decision-making. Persistent postpartum cardiovascular abnormalities further support the concept of pregnancy as a cardiovascular stress test and identify women at increased long-term cardiovascular risk. FGR should be viewed as the clinical manifestation of a complex maternal–placental–cardiovascular interaction rather than an isolated placental disorder. Maternal cardiovascular phenotyping has the potential to refine risk stratification, support hemodynamic-guided management, and identify women who may benefit from structured long-term cardiovascular surveillance.

27 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CMCosmin Minciuna
Cosmin Minciuna
DMDorina Adelina Minciuna
Dorina Adelina Minciuna
I(Ingrid Andrada Tanasa (Vasilache)
Ingrid Andrada Tanasa (Vasilache)
LMLucian Miron
Lucian Miron
Background/Objectives: Diffuse large B-cell lymphoma (DLBCL) remains clinically heterogeneous despite standard first-line immunochemotherapy. We evaluated whether machine learning (ML) models using routinely available diagnostic variables could predict primary refractory DLBCL. Materials and Methods: We performed a retrospective single-center study of 369 patients with DLBCL treated between 2015 and 2023. Primary refractory disease was defined as failure to achieve at least a partial response after first-line therapy. Logistic regression, random forest, gradient boosting, support vector machine with radial basis function kernel (SVM-RBF), and multilayer perceptron models were trained using baseline clinical and laboratory predictors. Performance was assessed using a stratified 80/20 holdout split, nested cross-validation, repeated random splits, and sensitivity analysis with complete hyperparameter retuning. Results: Primary refractory disease occurred in 111 patients (30.1%). In the holdout test set (n = 73), IPI achieved the highest discrimination (AUC 0.692; 95% CI 0.545–0.828). Among ML models, gradient boosting performed best (AUC 0.658; 95% CI 0.503–0.801), followed by SVM-RBF (AUC 0.619; 95% CI 0.471–0.760). DeLong comparisons showed no significant differences between ML models and IPI. In internal validation, gradient boosting showed the highest nested CV AUC (0.712 ± 0.049). Feature importance identified IPI as the dominant predictor. A weighted ML-derived clinical score identified a high-risk group with the highest refractory rate (52.9%), although the trend was not statistically significant (p = 0.063). Conclusions: ML models showed comparable but not superior performance to IPI for predicting primary refractory DLBCL. These findings support further external validation and development of multimodal clinically interpretable prediction frameworks for risk-adapted management.